POLYMED - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 2.3
Show all parameters (20 more)
🧾 Trade Setup
Buy at 1,725 ₹ with a stop-loss order at 1,690 ₹ – this leverages the strong volume and momentum while incorporating a necessary risk buffer. A further exit level would be 1,745 ₹ to capture additional upside potential if the price continues to move upwards. Overall, proceed with caution given the premium valuation and recent profit decline.
✅ Positive
Strong daily volume of 155k units indicates decent interest today. The recent EPS growth of 0.22% quarter-over-quarter suggests continued operational improvement, which could fuel short-term momentum. Furthermore, the DII holding increased by 0.48%, implying some institutional confidence.
⚠️ Limitation
The high P/E ratio of 51.6 relative to the industry PE of 33.1 indicates a premium valuation; this stock is potentially overvalued and susceptible to significant corrections if growth expectations aren't met, particularly given the recent profit decline. The negative MACD (-2.83) suggests weak momentum and bearish signals.
📉 Company Negative News
Recent news highlights declining net profits despite rising revenue, raising concerns about profitability sustainability and potential headwinds impacting investor sentiment today.
📈 Company Positive News
The company announced a 12.3% rise in FY26 revenue, suggesting continued growth prospects and potentially attracting buyers looking for expansion opportunities.
🏭 Industry
The pharmaceutical sector is generally resilient but sensitive to regulatory changes and patent expirations. Given the industry's average PE of 33.1, POLYMED’s current valuation appears elevated, reflecting broader market sentiment towards healthcare stocks.